BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-89 Cr | ₹-30 Cr | ₹-21 Cr | ₹-25 Cr | ₹-24 Cr |
What is the latest Cash Flow from Financing Activities ratio of BLISS GVS PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-89 Cr |
| Mar2025 | ₹-30 Cr |
| Mar2024 | ₹-21 Cr |
| Mar2023 | ₹-25 Cr |
| Mar2022 | ₹-24 Cr |
How is Cash Flow from Financing Activities of BLISS GVS PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-89 Cr | Negative | |
| Mar2025 | ₹-30 Cr | Negative | |
| Mar2024 | ₹-21 Cr | Negative | |
| Mar2023 | ₹-25 Cr | Negative | |
| Mar2022 | ₹-24 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹4,922.9 Cr | -5.3% | 0.8% | 195.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | -5.3% |
0.8% |
195.2% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses